Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

How Is IDEXX Laboratories’ Stock Performance Compared to Other Health Care Stocks?

Westbrook, Maine-based IDEXX Laboratories, Inc. (IDXX) is a global leader in veterinary diagnostics and animal-health technology, providing diagnostic instruments, rapid tests, laboratory services, and software primarily for companion animals, along with water-quality and livestock/dairy testing. Headquartered in Westbrook, Maine, and founded in 1983, the company operates in more than 170 countries and serves veterinarians, food-production facilities, and public health organizations. 

Companies worth $10 billion or more are typically classified as “large-cap stocks,” and IDXX fits the label perfectly. Its position as the global leader in veterinary diagnostics is supported by a highly diversified and integrated product ecosystem that includes in-clinic analyzers,...

Fundamentals

See More
  • Market Capitalization, $K 57,290,688
  • Shares Outstanding, K 79,851
  • Annual Sales, $ 3,898 M
  • Annual Income, $ 887,870 K
  • EBIT $ 1,306 M
  • EBITDA $ 1,436 M
  • 60-Month Beta 1.67
  • Price/Sales 14.87
  • Price/Cash Flow 58.40
  • Price/Book 37.13

Options Overview Details

View History
  • Implied Volatility 26.31% (-0.15%)
  • Historical Volatility 48.96%
  • IV Percentile 33%
  • IV Rank 16.42%
  • IV High 52.99% on 04/08/25
  • IV Low 21.07% on 08/12/25
  • Expected Move (DTE 14) 25.85 (3.62%)
  • Put/Call Vol Ratio 0.77
  • Today's Volume 122
  • Volume Avg (30-Day) 288
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 5,838
  • Open Int (30-Day) 6,196
  • Expected Range 688.25 to 739.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.93
  • Number of Estimates 7
  • High Estimate 3.00
  • Low Estimate 2.87
  • Prior Year 2.62
  • Growth Rate Est. (year over year) +11.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
665.25 +7.34%
on 11/18/25
769.98 -7.26%
on 11/26/25
-6.11 (-0.85%)
since 11/05/25
3-Month
600.57 +18.90%
on 10/01/25
769.98 -7.26%
on 11/26/25
+71.11 (+11.06%)
since 09/05/25
52-Week
356.14 +100.51%
on 04/09/25
769.98 -7.26%
on 11/26/25
+286.61 (+67.04%)
since 12/05/24

Most Recent Stories

More News
How Is IDEXX Laboratories’ Stock Performance Compared to Other Health Care Stocks?

Although IDEXX Laboratories has outperformed the healthcare sector over the past year, analysts remain cautiously optimistic about the stock’s prospects.

XLV : 153.26 (-0.42%)
ZTS : 118.65 (-1.46%)
IDXX : 714.10 (-0.47%)
Danaher Stock: Is DHR Underperforming the Healthcare Sector?

Despite Danaher’s underperformance relative to the healthcare sector, Wall Street analysts remain strongly optimistic about the stock’s prospects.

XLV : 153.26 (-0.42%)
IDXX : 714.10 (-0.47%)
DHR : 226.25 (-0.39%)
Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector?

Thermo Fisher Scientific has outperformed the broader healthcare sector over the past year, and analysts continue to hold a strongly bullish view on its growth prospects.

XLV : 153.26 (-0.42%)
TMO : 572.77 (-0.43%)
IDXX : 714.10 (-0.47%)
What Are Wall Street Analysts' Target Price for IDEXX Laboratories Stock?

IDEXX Laboratories has considerably outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

XHE : 89.34 (-0.06%)
$SPX : 6,870.40 (+0.19%)
JPM : 315.04 (-0.34%)
IDXX : 714.10 (-0.47%)
Stock Index Futures Plunge on Valuation Concerns

December S&P 500 E-Mini futures (ESZ25) are down -1.01%, and December Nasdaq 100 E-Mini futures (NQZ25) are down -1.31% this morning as quarterly results from AI bellwether Palantir failed to impress investors...

NVDA : 182.41 (-0.53%)
ANET : 128.59 (+0.03%)
SPOT : 564.93 (+0.71%)
SRPT : 22.26 (-2.45%)
GEBN.Z.EB : 621.400 (+0.47%)
MU : 237.22 (+4.66%)
FN : 478.45 (+1.41%)
NQZ25 : 25,732.00s (+0.43%)
AMGN : 329.89 (-3.02%)
PFE : 26.03 (+1.28%)
EDEN.P.DX : 18.910 (+1.83%)
SHOP : 161.08 (-0.76%)
Idexx: Q3 Earnings Snapshot

Idexx: Q3 Earnings Snapshot

IDXX : 714.10 (-0.47%)
IDEXX Laboratories Announces Third Quarter Results

Achieves third quarter revenue growth of 13% as reported and 12% organic, and CAG Diagnostics recurring revenue growth of 11% as reported and 10% organic. ...

IDXX : 714.10 (-0.47%)
What to Expect From IDEXX Laboratories’ Q3 2025 Earnings Report

IDEXX Laboratories is set to announce its third-quarter results next month, with analysts forecasting robust double-digit growth in earnings.

XLV : 153.26 (-0.42%)
$SPX : 6,870.40 (+0.19%)
IDXX : 714.10 (-0.47%)
IDEXX Laboratories to Release 2025 Third Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 third quarter financial results for Monday, November 3, 2025, before...

IDXX : 714.10 (-0.47%)
IDEXX Laboratories Appoints Karen Peacock to Board

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Idexx Laboratories...

IDXX : 714.10 (-0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care...

See More

Key Turning Points

3rd Resistance Point 733.23
2nd Resistance Point 727.97
1st Resistance Point 721.03
Last Price 714.10
1st Support Level 708.84
2nd Support Level 703.58
3rd Support Level 696.64

See More

52-Week High 769.98
Last Price 714.10
Fibonacci 61.8% 611.89
Fibonacci 50% 563.06
Fibonacci 38.2% 514.23
52-Week Low 356.14

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar